Setup
The proliferation of infections that can not be treated is a nightmare scenario we have not done nearly enough to prevent. Half of all prescriptions written for antibiotics in the US are still inappropriate and new medicines are barely trickling through clinical development. And now comes the MCR-1 gene, which renders bacteria resistant to colistin, the final antibiotic line of defense against recalcitrant infections like CRE. MCR-1’s ability to transfer resistance from one bacterial species to another may ultimately result in untreatable infections. How large is that risk? What will it take to prevent it?
Explore More
Health
Did you know that only 7% of the investments made within the $715 billion global impact investing market go toward health? Learn how Johnson & Johnson Impact Ventures is leadi...
Two pioneering doctors are saving lives and making surgeries safer with new, innovative approaches. Presented by Mount Sinai Health System
If you're fully vaccinated, are you protected from COVID-19? Will we need booster shots? What's the best way to keep children safe as they return to school? Infectious disease...
From blockchain to back to school and virus-hunting to bridging divides, speakers at the 2021 Aspen Ideas Festival addressed issues in a new kind of world—one touched, and cha...
Building on lessons learned from the COVID-19 pandemic, there are significant opportunities to expand the use of rapid testing to address many health challenges around the wor...
Faced with the COVID-19 pandemic, the healthcare industry had to quickly adapt to confront the rapidly evolving challenges facing its patients, customers, and employees. Learn...
